Alterity Therapeutics Ltd. (AU:ATH) has released an update.
JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Alterity Therapeutics Ltd., with changes in their holdings including securities lending agreements, rehypothecation, and principal sales and purchases. The financial activities leading to this status change were completed by May 3, 2024, ending a significant investment relationship that began before March 2024.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.
